ArticleBMC pregnancy and childbirth2025
Investigation of pancreatic size and clinical effects in cases with late-onset fetal growth restriction.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of our study was to evaluate fetal pancreas size in cases of isolated late-onset fetal growth restriction (FGR) and to assess its relationship with clinical and laboratory findings in the early neonatal period.
methodsPregnant individuals diagnosed with late-onset FGR according to Delphi consensus criteria formed the study group, while healthy pregnant women matched for gestational age formed the control group. Fetal pancreatic circumference and corresponding percentile value and fetal abdominal circumference to pancreas circumference (FACPC) ratio measurements were obtained. Neonatal blood sugar levels, admission to the neonatal intensive care unit (NICU), and other metabolic parameters were recorded.
resultsA total of 154 pregnant individuals, including 67 FGR and 87 healthy control groups, were included in our study. The pancreatic circumference and pancreatic circumference percentile were significantly lower in the FGR group (p < 0.001). There was no significant difference between the two groups in terms of FACPC ratio (p = 0.74). A statistically significant positive correlation was observed between the FACPC ratio and neonatal blood glucose levels (r = 0.298, p = 0.01). However, no significant correlation was observed between fetal pancreas size and short-term clinical and laboratory neonatal outcomes such as hypoglycemia or admission to the neonatal intensive care unit.
conclusionIn our ultrasound-based imaging study, we quantitatively assessed fetal pancreas size in cases of late-onset FGR. Pancreatic size was significantly lower in the FGR group. There was a significant positive correlation between FACPC ratio and neonatal blood glucose levels. The results of this study provide preliminary evidence of the possible effects of fetal pancreatic development on fetal growth and perinatal metabolic regulation. In clinical practice, fetal pancreatic biometry could be considered as an adjunct parameter during ultrasound evaluations of FGR cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.